PFA
Pathway Financial Advisers’s Eli Lilly LLY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.39M | Buy |
1,787
+123
| +7% | +$95.9K | 0.45% | 75 |
|
|
2025
Q1 | $1.37M | Buy |
1,664
+478
| +40% | +$395K | 0.47% | 72 |
|
|
2024
Q4 | $915K | Sell |
1,186
-1,021,202
| -100% | -$788M | 0.31% | 94 |
|
|
2024
Q3 | $1.15K | Buy |
1,022,388
+1,021,287
| +92,760% | +$1.15K | ﹤0.01% | 371 |
|
|
2024
Q2 | $982K | Buy |
1,101
+44
| +4% | +$39.3K | 0.35% | 90 |
|
|
2024
Q1 | $823K | Buy |
1,057
+82
| +8% | +$63.8K | 0.3% | 99 |
|
|
2023
Q4 | $568K | Buy |
975
+99
| +11% | +$57.7K | 0.22% | 114 |
|
|
2023
Q3 | $471K | Buy |
+876
| New | +$471K | 0.19% | 118 |
|
|
2023
Q1 | $323K | Sell |
940
-250
| -21% | -$86K | 0.13% | 139 |
|
|
2022
Q4 | $436K | Buy |
+1,190
| New | +$436K | 0.18% | 119 |
|